Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome

Clinical Microbiology and Infection

Volumn 21, Issue 9, 2015, Pages 852.e1-852.e9

  Heikema, A P ^a   Islam, Z ^b   Horst Kreft, D ^a   Huizinga, R ^a   Jacobs, B C ^a   Wagenaar, J A ^c,d   Poly, F ^e   Guerry, P ^e   van Belkum, A ^f   Parker, C T ^g   Endtz, H P ^a,b,h  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c UTRECHT UNIVERSITY   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e NAVAL MEDICAL RESEARCH CENTER   (United States)

^f BIOMÉRIEUX   (France)

^g WESTERN REGIONAL RESEARCH CENTER   (United States)

^h Fondation Mérieux Applied Research   (France)

Author keywords

Campylobacter jejuni; Capsular genotype; Guillain Barr syndrome; Lipo oligosaccharide; Multilocus sequence typing

Indexed keywords

LIPOOLIGOSACCHARIDE; POLYSACCHARIDE;

ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTERITIS; FECES ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; GUILLAIN BARRE SYNDROME; HS14 GENE; HS19 GENE; HS2 GENE; HUMAN; MULTILOCUS SEQUENCE TYPING; PATHOGENESIS; POPULATION; PRIORITY JOURNAL; BACTERIAL CAPSULE; BANGLADESH; CAMPYLOBACTERIOSIS; CLASSIFICATION; COMPLICATION; GENETICS; GUILLAIN-BARRE SYNDROME; MICROBIOLOGY; NETHERLANDS;

CAMPYLOBACTER JEJUNI;

BACTERIAL CAPSULES; BANGLADESH; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; GENOTYPE; GUILLAIN-BARRE SYNDROME; HUMANS; NETHERLANDS;

EID: 84940614561     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.05.031     Document Type: Article

References (37)

1. Havelaar A.H., Ivarsson S., Lofdahl M., Nauta M.J. Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009. Epidemiol Infect 2013, 141:293-302.
2. Scallan E., Hoekstra R.M., Angulo F.J., Tauxe R.V., Widdowson M.A., Roy S.L., et al. Foodborne illness acquired in the United States - major pathogens. Emerg Infect Dis 2011, 17:7-15.
3. Allos B.M. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001, 32:1201-1206.
4. Hughes R.A., Cornblath D.R. Guillain-Barré syndrome. Lancet 2005, 366:165366.
5. Winer J.B., Hughes R.A.C., Anderson M.J., Jones D.M., Kangro H., Watkins R.P. Aprospective study of acute idiopathic neuropathy. Ii. Antecedent events. JNeurol Neurosurg Psychiatry 1988, 51:613-618.
6. Alshekhlee A., Hussain Z., Sultan B., Katirji B. Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology 2008, 70:1608-1613.
7. Fisher M. An unusual variant of acute idiopathic polyneuritis: syndrome of ophthalmoplegia, ataxia and areflexia. NEngl J Med 1956, 255:57-65.
8. Dingle K.E., van den Braak N., Colles F.M., Price L.J., Woodward D.L., Rodgers F.G., et al. Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barré and Miller-Fisher syndromes are of diverse genetic lineage, serotype and flagella type. JClin Microbiol 2001, 39:3346-3349.
9. Louwen R., Horst-Kreft D., de Boer A.G., van der Graaf L., de Knegt G., Hamersma M., et al. Anovel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndromé. Eur J Clin Microbiol Infect Dis 2012.
10. Yuki N., Susuki K., Koga M., Nishimoto Y., Odaka M., Hirata K., et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. PNAS 2004, 101:11404-11409.
11. Godschalk P.C., Heikema A.P., Gilbert M., Komagamine T., Ang C.W., Glerum J., et al. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome. JClin Invest 2004, 114:1659-1665.
12. Parker C.T., Gilbert M., Yuki N., Endtz H.P., Mandrell R.E. Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations. JBacteriol 2008, 190:5681-5689.
13. Eucker T.P., Konkel M.E. The cooperative action of bacterial fibronectin-binding proteins and secreted proteins promote maximal Campylobacter jejuni invasion of host cells by stimulating membrane ruffling. Cell Microbiol 2012, 14:226-238.
14. Jain D., Prasad K.N., Sinha S., Vishwakarma A.L. Cell cycle arrest & apoptosis of epithelial cell line by cytolethal distending toxin positive Campylobacter jejuni. Indian J Med Res 2009, 129:418-423.
15. Talukder K.A., Aslam M., Islam Z., Azmi I.J., Dutta D.K., Hossain S., et al. Prevalence of virulence genes and cytolethal distending toxin production in Campylobacter jejuni isolates from diarrheal patients in Bangladesh. JClin Microbiol 2008, 46:1485-1488.
16. Datta S., Niwa H., Itoh K. Prevalence of 11 pathogenic genes of Campylobacter jejuni by PCR in strains isolated from humans, poultry meat and broiler and bovine faeces. JMed Microbiol 2003, 52:345-348.
17. Bacon D.J., Szymanski C.M., Burr D.H., Silver R.P., Alm R.A., Guerry P. Aphase-variable capsule is involved in virulence of Campylobacter jejuni 81-176. Mol Microbiol 2001, 40:769-777.
18. Keo T., Collins J., Kunwar P., Blaser M.J., Iovine N.M. Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials. Virulence 2011, 2:30-40.
19. Rose A., Kay E., Wren B.W., Dallman M.J. The Campylobacter jejuni NCTC11168 capsule prevents excessive cytokine production by dendritic cells. Med Microbiol Immunol 2012, 201:137-144.
20. Karlyshev A.V., Champion O.L., Churcher C., Brisson J.R., Jarrell H.C., Gilbert M., et al. Analysis of Campylobacter jejuni capsular loci revealsmultiple mechanisms for the generation of structural diversity and the ability to form complex heptoses. Mol Microbiol 2005, 55:90-103.
21. Penner J.L., Hennessy J.N., Congi R.V. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur J Clin Microbiol 1983, 2:378-383.
22. Kuroki S., Saida T., Nukina M., Haruta T., Yoshioka M., Kobayashi Y., et al. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-n-acetylglucosamine residues. Ann Neurol 1993, 33:243-247.
23. Lastovica A.J., Goddard E.A., Argent A.C. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains. JInfect Dis 1997, 176:S139-S143.
24. Islam Z., van Belkum A., Wagenaar J.A., Cody A.J., de Boer A.G., Tabor H., et al. Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh. PLoS ONE 2009, 4:e7257.
25. Allos B.M., Lippy F.T., Carlsen A., Washburn R.G., Blaser M.J. Campylobacter jejuni strains from patients with Guillain-Barré Syndrome. Emerg Infect Dis 1998, 4:263-268.
26. Poly F., Serichatalergs O., Schulman M., Ju J., Cates C.N., Kanipes M., et al. Discrimination of major capsular types of Campylobacter jejuni by multiplex PCR. JClin Microbiol 2011, 49:1750-1757.
27. Doorduyn Y., Van Den Brandhof W.E., Van Duynhoven Y.T., Breukink B.J., Wagenaar J.A., Van Pelt W. Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in The Netherlands: a case-control study. Epidemiol Infect 2010, 138:1391-1404.
28. Doorduyn Y., Van Den Brandhof W.E., Van Duynhoven Y.T., Wannet W.J., Van Pelt W. RGuillain-Barré syndrome (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in enteritidis and sandboxes in typhimurium infections. Epidemiol Infect 2006, 134:617-626.
29. Preston M.A., Penner J.L. Characterization of cross-reacting serotypes of Campylobacter jejuni. Can J Microbiol 1989, 35:265-273.
30. Pike B.L., Guerry P., Poly F. Global distribution of penner serotypes: a systematic review. PLoS ONE 2013, 8:e67375.
31. Islam Z., van Belkum A., Cody A.J., Tabor H., Jacobs B.C., Talukder K.A., et al. Campylobacter jejuni HS:23 and Guillain-Barré syndrome, Bangladesh. Emerg Infect Dis 2009, 15:1315-1317.
32. Nachamkin I., Engberg J., Gutacker M., Meinersman R.J., Li C.Y., Arzate P., et al. Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. JInfect Dis 2001, 184:221-226.
33. Wassenaar T.M., Fry B.N., Lastovica A.J., Wagenaar J.A., Coloe P.J., Duim B. Genetic characterization of Campylobacter jejuni O:41 isolates in relation with Guillain-Barré syndrome. JClin Microbiol 2000, 38:874-876.
34. Yabe S., Higuchi W., Iwao Y., Takano T., Razvina O., Reva I., et al. Molecular typing of Campylobacter jejuni and C.coli from chickens and patients with gastritis or Guillain-Barré syndrome based on multilocus sequence types and pulsed-field gel electrophoresis patterns. Microbiol Immunol 2010, 54:362-367.
35. Quinones B., Guilhabert M.R., Miller W.G., Mandrell R.E., Lastovica A.J., Parker C.T. Comparative genomic analysis of clinical strains of Campylobacter jejuni from South Africa. PLoS ONE 2008, 3:e2015.
36. Gaasbeek E.J., Wagenaar J.A., Guilhabert M.R., Wosten M.M., van Putten J.P., van der Graaf-van Bloois L., et al. ADNase encoded by integrated element CJE1 inhibits natural transformation of Campylobacter jejuni. JBacteriol 2009, 191:2296-2306.
37. Gilbert M., Godschalk P.C.R., Karwaski M.F., Ang W.C., van Belkum A., Li J., et al. Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchange. Infect Immun 2004, 72:1162-1165.